Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway

Fig. 1

Network pharmacology. A Structural formula for ammidin. B Venn diagram of Angelica dahurica and ferroptosis. C Cross-PPI networks. D PPI network core screening. GO results for E biological processes, F cellular components and G molecular function. H Results of KEGG enrichment analysis (P < 0.05). I The left picture shows the overall picture of the interaction between protein mTOR and small molecule ammidin, and the right picture is a 3D view of mTOR and ammidin. J AMPK and ammidin. K ACSL4 and ammidin. PPI, protein-protein interactions; KEGG, Kyoto Encyclopedia of Genes and Genomes; ACSL4, Acyl-CoA synthetase long chain family member 4

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us